デフォルト表紙
市場調査レポート
商品コード
1619416

抗体の世界市場レポート 2024年

Antibodies Global Market Report 2024


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
抗体の世界市場レポート 2024年
出版日: 2024年12月20日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

抗体の市場規模は今後数年で急成長が見込まれます。2028年の年間平均成長率(CAGR)は15.2%で、5,049億9,000万米ドルに成長します。予測期間中に予想される成長は、がん研究の増加、免疫療法の応用拡大、モノクローナル抗体の使用増加、臨床検査数の増加、精密医療の採用拡大などに起因しています。予測期間の主要動向としては、先進的バイオ製造技術の採用、抗体工学の進歩、高性能スクリーニング法の統合、次世代シーケンシング技術の使用、新規デリバリーシステムの開発などが挙げられます。

自己免疫疾患の有病率の増加は、抗体市場の成長を促進すると予想されます。自己免疫疾患は、免疫系が誤って自己の組織を標的とし、損傷を与える疾患であり、関節リウマチ、ループス、多発性硬化症などの疾患が含まれます。自己免疫疾患の罹患率の増加は、環境要因、遺伝的素因、ライフスタイルの変化に関連しています。抗体は、身体の組織を誤って攻撃する特定の免疫細胞や炎症分子を標的にして中和し、炎症を抑えて症状を緩和するため、この文脈において極めて重要です。例えば、2024年5月、英国を拠点とする非営利団体である国際多発性硬化症連盟は、世界の多発性硬化症患者数が2020年の280万人から2023年には290万人に増加すると報告しました。その結果、自己免疫疾患の有病率の増加が抗体市場の拡大に寄与しています。

抗体市場の主要企業は、診断と治療の両方で精度を向上させ、一貫した結果を保証するために、検証済み抗体の開発に注力しています。バリデートされた抗体とは、対象タンパク質の検出精度と特異性のテストと確認を受けたものです。この検証により、研究結果の信頼性と抗体医薬品の有効性が高まります。例えば、2024年3月、米国のライフサイエンス研究と臨床診断会社であるBio-Rad Laboratoriesは、希少細胞と循環腫瘍細胞(CTC)の列挙用に設計されたCelselectスライド検証済み抗体を発表しました。この進歩により、腫瘍の不均一性と疾患進行の研究が強化されます。Bio-RadのCelselect Slides Enumeration Stain Kitsと互換性のある有効な抗体は、正確なCTC検出を容易にし、がん研究と診断における重要な進歩を意味します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の抗体市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の抗体市場の実績:規模と成長、2018~2023年
  • 世界の抗体市場の予測:規模と成長、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の抗体市場:製品タイプ別、実績と予測、2018~2023年、2023~2028年、2033年
  • モノクローナル抗体
  • ポリクローナル抗体
  • 抗体薬剤複合体
  • 世界の抗体市場:疾患適応症別、実績と予測、2018~2023年、2023~2028年、2033年
  • 心血管疾患
  • 中枢神経系(CNS)障害
  • がん
  • 自己免疫疾患
  • その他
  • 世界の抗体市場:エンドユーザー別、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院
  • 長期ケア施設
  • 研究機関
  • その他

第7章 地域別・国別分析

  • 世界の抗体市場:地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の抗体市場:国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 抗体市場:競合情勢
  • 抗体市場:企業プロファイル
    • Pfizer Inc.
    • Johnson & Johnson Services Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co Inc.
    • AbbVie Inc.

第31章 その他の大手企業と革新的企業

  • Sanofi S.A.
  • Bristol Myers Squibb Company
  • Novartis AG
  • GSK plc
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Amgen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Biogen Inc.
  • Alexion Pharmaceuticals Inc.
  • Incyte Corporation
  • Kyowa Kirin Co Ltd
  • Ultragenyx Pharmaceutical Inc
  • Xencor Inc.
  • MacroGenics Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r20447

Antibodies are proteins produced by the immune system in response to foreign substances such as bacteria or viruses. They recognize and attach to antigens, which are specific molecules found on the surface of these invaders. This attachment either neutralizes the pathogen or signals other immune cells to destroy it. Antibodies are a crucial part of the adaptive immune system, with each one targeting a specific antigen.

The main product types in the antibodies market include monoclonal antibodies, polyclonal antibodies, and antibody-drug conjugates. Monoclonal antibodies are lab-created molecules engineered to specifically target certain proteins or antigens within the body. These products are used for various disease indications, such as cardiovascular diseases, central nervous system (CNS) disorders, cancer, autoimmune diseases, and more, and are utilized by hospitals, long-term care facilities, research institutions, and others.

The antibodies market research report is one of a series of new reports from The Business Research Company that provides antibodies market statistics, including the antibodies industry global market size, regional shares, competitors with antibodies market share, detailed antibodies market segments, market trends, and opportunities, and any further data you may need to thrive in the antibodies industry. These antibodies market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antibodies market size has grown rapidly in recent years. It will grow from $249.13 billion in 2023 to $286.81 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth observed in the historic period can be attributed to an increase in the prevalence of chronic diseases, a rise in the number of clinical trials, an expansion of therapeutic areas, growing awareness of personalized medicine, and an increase in diagnostic applications.

The antibodies market size is expected to see rapid growth in the next few years. It will grow to $504.99 billion in 2028 at a compound annual growth rate (CAGR) of 15.2%. The growth anticipated during the forecast period can be attributed to a rise in cancer research, expanding applications of immunotherapy, increasing use of monoclonal antibodies, a growing number of clinical trials, and greater adoption of precision medicine. Key trends for the forecast period include the adoption of advanced biomanufacturing technologies, advancements in antibody engineering, the integration of high-throughput screening methods, the use of next-generation sequencing technologies, and the development of novel delivery systems.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the antibodies market. Autoimmune diseases are conditions where the immune system mistakenly targets and damages its own tissues, including disorders such as rheumatoid arthritis, lupus, and multiple sclerosis. The rising incidence of autoimmune diseases is linked to environmental factors, genetic predispositions, and lifestyle changes. Antibodies are critical in this context as they target and neutralize specific immune cells or inflammatory molecules that erroneously attack the body's tissues, thus reducing inflammation and alleviating symptoms. For example, in May 2024, the Multiple Sclerosis International Federation, a UK-based non-profit organization, reported an increase in the global number of people with multiple sclerosis from 2.8 million in 2020 to 2.9 million in 2023. Consequently, the growing prevalence of autoimmune diseases is contributing to the expansion of the antibodies market.

Leading companies in the antibodies market are focusing on developing validated antibodies to improve accuracy and ensure consistent results in both diagnostics and therapeutics. Validated antibodies are those that have undergone testing and confirmation for accuracy and specificity in detecting target proteins. This validation enhances the reliability of research findings and the effectiveness of antibody-based products. For instance, in March 2024, Bio-Rad Laboratories, a US-based life science research and clinical diagnostics company, introduced Celselect slides validated antibodies designed for rare cell and circulating tumor cell (CTC) enumeration. This advancement enhances the study of tumor heterogeneity and disease progression. The validated antibodies, compatible with Bio-Rad's Celselect Slides Enumeration Stain Kits, facilitate precise CTC detection, representing a significant advancement in cancer research and diagnostics.

In June 2024, Johnson & Johnson Services Inc., a US-based pharmaceutical and medical device company, acquired Proteologix Inc. for $850 million. This acquisition aims to strategically advance Johnson & Johnson's development of innovative treatments for immune-mediated diseases by integrating Proteologix's advanced bispecific antibodies. The acquisition aligns with Johnson & Johnson's objective to enhance its immunology portfolio with effective and optimized therapies for conditions such as atopic dermatitis and asthma. Proteologix Inc. is a US-based provider of antibodies.

Major companies operating in the antibodies market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Alexion Pharmaceuticals Inc., Incyte Corporation, Kyowa Kirin Co Ltd, Ultragenyx Pharmaceutical Inc, Xencor Inc., MacroGenics Inc., ImmunoGen Inc., Sorrento Therapeutics Inc., Beam Therapeutics Inc., SAB Biotherapeutics Inc., bluebird bio Inc., Iovance Biotherapeutics Inc.

North America was the largest region in the antibodies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibodies market consists of sales of recombinant antibodies, antibody-based assays, bispecific antibodies, single domain antibodies, humanized antibodies, and diagnostic kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibodies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antibodies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibodies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Monoclonal Antibodies; Polyclonal Antibodies; Antibody Drug Complexes
  • 2) By Disease Indication: Cardiovascular Diseases; Central Nervous System (CNS) Disorders; Cancer; Autoimmune Disorders; Other Indications
  • 3) By End User: Hospitals; Long Term Care Facilities; Research Institutes; Other End Users
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antibodies Market Characteristics

3. Antibodies Market Trends And Strategies

4. Antibodies Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Antibodies Market Size and Growth

  • 5.1. Global Antibodies Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Antibodies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Antibodies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Antibodies Market Segmentation

  • 6.1. Global Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Antibody Drug Complexes
  • 6.2. Global Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular Diseases
  • Central Nervous System (CNS) Disorders
  • Cancer
  • Autoimmune Disorders
  • Other Indications
  • 6.3. Global Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Long Term Care Facilities
  • Research Institutes
  • Other End Users

7. Antibodies Market Regional And Country Analysis

  • 7.1. Global Antibodies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Antibodies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Antibodies Market

  • 8.1. Asia-Pacific Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Antibodies Market

  • 9.1. China Antibodies Market Overview
  • 9.2. China Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Antibodies Market

  • 10.1. India Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Antibodies Market

  • 11.1. Japan Antibodies Market Overview
  • 11.2. Japan Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Antibodies Market

  • 12.1. Australia Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Antibodies Market

  • 13.1. Indonesia Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Antibodies Market

  • 14.1. South Korea Antibodies Market Overview
  • 14.2. South Korea Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Antibodies Market

  • 15.1. Western Europe Antibodies Market Overview
  • 15.2. Western Europe Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Antibodies Market

  • 16.1. UK Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Antibodies Market

  • 17.1. Germany Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Antibodies Market

  • 18.1. France Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Antibodies Market

  • 19.1. Italy Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Antibodies Market

  • 20.1. Spain Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Antibodies Market

  • 21.1. Eastern Europe Antibodies Market Overview
  • 21.2. Eastern Europe Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Antibodies Market

  • 22.1. Russia Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Antibodies Market

  • 23.1. North America Antibodies Market Overview
  • 23.2. North America Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Antibodies Market

  • 24.1. USA Antibodies Market Overview
  • 24.2. USA Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Antibodies Market

  • 25.1. Canada Antibodies Market Overview
  • 25.2. Canada Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Antibodies Market

  • 26.1. South America Antibodies Market Overview
  • 26.2. South America Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Antibodies Market

  • 27.1. Brazil Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Antibodies Market

  • 28.1. Middle East Antibodies Market Overview
  • 28.2. Middle East Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Antibodies Market

  • 29.1. Africa Antibodies Market Overview
  • 29.2. Africa Antibodies Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Antibodies Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Antibodies Market Competitive Landscape And Company Profiles

  • 30.1. Antibodies Market Competitive Landscape
  • 30.2. Antibodies Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Antibodies Market Other Major And Innovative Companies

  • 31.1. Sanofi S.A.
  • 31.2. Bristol Myers Squibb Company
  • 31.3. Novartis AG
  • 31.4. GSK plc
  • 31.5. Takeda Pharmaceutical Company Limited
  • 31.6. Eli Lilly and Company
  • 31.7. Amgen Inc.
  • 31.8. Regeneron Pharmaceuticals Inc.
  • 31.9. Biogen Inc.
  • 31.10. Alexion Pharmaceuticals Inc.
  • 31.11. Incyte Corporation
  • 31.12. Kyowa Kirin Co Ltd
  • 31.13. Ultragenyx Pharmaceutical Inc
  • 31.14. Xencor Inc.
  • 31.15. MacroGenics Inc.

32. Global Antibodies Market Competitive Benchmarking

33. Global Antibodies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Antibodies Market

35. Antibodies Market Future Outlook and Potential Analysis

  • 35.1 Antibodies Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Antibodies Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Antibodies Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer